Sarepta Therapeutics (SRPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SRPT | AMGN | BMY | GILD | VRTX |
| Company | Sarepta Therapeutics | Amgen Inc | Bristol-Myers Squibb Company | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 117.66 | 270.63 | 49.00 | 66.58 | 404.50 |
| High | 118.72 | 274.42 | 49.00 | 67.03 | 406.83 |
| Low | 117.21 | 269.65 | 48.55 | 66.37 | 399.37 |
| Last | 117.43 | 273.96 | 48.78 | 67.09 | 399.88 |
| Change | +0.31 | +0.42 | -0.21 | +0.06 | -5.03 |
| % Change | +0.26% | +0.15% | -0.43% | +0.09% | -1.24% |
| Volume | 163,399 | 521,710 | 3,845,645 | 2,191,609 | 274,769 |
| 20-Day Average Volume | 603,108 | 2,073,098 | 10,632,788 | 6,168,365 | 942,512 |
| Previous Close | 117.12 | 273.54 | 48.99 | 67.03 | 404.91 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 122.91 | 271.60 | 50.36 | 69.06 | 403.32 |
| 20-Day Raw Stochastic | 19.12% | 48.00% | 15.82% | 11.36% | 34.28% |
| 20-Day Relative Strength | 40.85% | 49.22% | 40.48% | 32.17% | 45.30% |
| Weighted Alpha | +7.13 | +11.74 | -26.35 | -21.23 | +16.36 |
| Today's Opinion | 40% Buy | 40% Sell | 88% Sell | 100% Sell | 8% Buy |
| Previous Opinion | 40% Buy | 40% Sell | 88% Sell | 100% Sell | 24% Buy |
| Last Month's Opinion | 72% Buy | 24% Buy | 8% Sell | 88% Sell | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.26% since 04/17/24 | +3.78% since 04/17/24 | +1.80% since 04/17/24 | -0.19% since 04/17/24 | +2.12% since 04/17/24 |
| Low | 114.37 on 04/19/24 | 260.68 on 04/19/24 | 47.62 on 04/18/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 |
| High | 119.91 on 04/23/24 | 274.48 on 04/23/24 | 49.56 on 04/22/24 | 67.68 on 04/23/24 | 406.86 on 04/23/24 |
| 1-Month | |||||
| %Chg | -7.81% since 03/22/24 | -0.76% since 03/22/24 | -6.22% since 03/22/24 | -7.99% since 03/22/24 | -3.42% since 03/22/24 |
| Low | 114.37 on 04/19/24 | 260.68 on 04/19/24 | 47.62 on 04/18/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 |
| High | 131.16 on 03/28/24 | 288.57 on 03/28/24 | 54.47 on 03/28/24 | 73.87 on 03/28/24 | 421.45 on 04/01/24 |
| 3-Month | |||||
| %Chg | -2.20% since 01/24/24 | -10.29% since 01/24/24 | -3.07% since 01/24/24 | -16.00% since 01/24/24 | -6.11% since 01/24/24 |
| Low | 114.37 on 04/19/24 | 260.68 on 04/19/24 | 47.58 on 02/06/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 |
| High | 143.00 on 02/16/24 | 329.72 on 02/05/24 | 55.03 on 03/13/24 | 81.06 on 01/25/24 | 448.40 on 01/30/24 |
| 6-Month | |||||
| %Chg | +3.67% since 10/24/23 | -0.74% since 10/24/23 | -13.22% since 10/24/23 | -14.52% since 10/24/23 | +8.68% since 10/24/23 |
| Low | 55.25 on 10/31/23 | 249.70 on 10/31/23 | 47.58 on 02/06/24 | 65.90 on 04/18/24 | 341.90 on 11/16/23 |
| High | 143.00 on 02/16/24 | 329.72 on 02/05/24 | 56.77 on 10/25/23 | 87.86 on 01/19/24 | 448.40 on 01/30/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 10,997,569 | 146,720,288 | 99,290,928 | 83,457,512 | 104,652,640 |
| Shares Outstanding, K | 93,900 | 536,376 | 2,026,759 | 1,245,077 | 258,459 |
| Annual Sales | 1,243,340,000 | 28,190,000,000 | 45,006,000,000 | 27,116,000,000 | 9,869,200,000 |
| Annual Net Income | -535,980,000 | 6,717,000,000 | 8,025,000,000 | 5,665,000,000 | 3,619,600,000 |
| Last Quarter Sales | 396,780,000 | 8,196,000,000 | 11,477,000,000 | 7,114,000,000 | 2,517,700,000 |
| Last Quarter Net Income | 45,650,000 | 767,000,000 | 1,762,000,000 | 1,429,000,000 | 968,800,000 |
| 60-Month Beta | 0.94 | 0.58 | 0.39 | 0.19 | 0.35 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.47 on 02/28/24 | 4.71 on 02/06/24 | 1.70 on 02/02/24 | 1.72 on 02/06/24 | 4.20 on 02/05/24 |
| Latest Earnings Date | 05/07/24 | 05/02/24 | 04/25/24 | 04/25/24 | 05/06/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.600 on 04/04/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 04/04/24 | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.58 | 6.55 | 9.96 | 29.76 |